Breast Cancer Now responds to approval of Perjeta for treating primary breast cancer following surgery

In final draft guidance, NICE has approved Perjeta – given in combination with trastuzumab and chemotherapy – as a new option after surgery for some...

15 February 2019

Annual screening detects breast cancers earlier for women aged 35-39 with a family history, major UK trial finds

Our research has provided strong evidence that women aged 35-39 at a moderate or high risk of developing breast cancer, could benefit from annual...

11 February 2019

Manchester scientist finding ways to stop breast cancer spreading

A leading Manchester scientist has been awarded a prestigious fellowship by Breast Cancer Now to investigate whether targeting two key proteins could...

4 February 2019

Bradford scientists awarded over £280k to develop new ultra-potent chemotherapy for breast cancer

Two leading Bradford scientists have been awarded a combined total of more than £280,000 by research charity Breast Cancer Now, to develop a new type...

4 February 2019

Epigenetic changes may predict recurrence following aromatase inhibitor therapy, new study suggests

Researchers part-funded by Breast Cancer Now have identified changes in breast cancer cells that could in future help predict the likelihood of...

21 January 2019

We respond to monthly NHS England breast cancer waiting times: November 2018

The two-week wait for people referred with suspected breast cancer was missed. The target is 93%, but only 90.51% of patients were seen within two...

11 January 2019

Breast Cancer Care launches online toolkit for secondary breast cancer nurses

Leading support charity Breast Cancer Care has today (Wednesday 9 January 2019) launched an online toolkit for secondary breast cancer nurses across...

10 January 2019

Conflicting diet information has devastating impact on mental health, warns breast cancer charity

New figures released today by national charity Breast Cancer Care reveal the devastating impact on women with breast cancer of conflicting...

8 January 2019

Antibody immunotherapy could provide long-awaited new option for triple negative breast cancer

Targeted antibody therapies – including a new antibody immunotherapy – could offer “long-awaited” advances for patients with aggressive ‘triple...

17 December 2018